Microbio Co

Microbio Co ROE

The Return on Equity (ROE) of Microbio Co (4128.TWO) as of Nov 19, 2026 is -8.50 %. In the previous year, Return on Equity (ROE) was -10.68 % — a change of -20.42% (higher).

ROE

-8.50 %

YoY

-20.42%

Last updated:

In 2025, Microbio Co's return on equity (ROE) was -8.50 %, a -20.42% increase from the -10.68 % ROE in the previous year.

The Microbio Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-9.42 TWD
Jan 1, 2019
-3.94 TWD
Jan 1, 2020
4.89 TWD
Jan 1, 2021
-1.96 TWD
Jan 1, 2022
1.26 TWD
Jan 1, 2023
-9.99 TWD
Jan 1, 2024
-10.68 TWD
Jan 1, 2025
-8.50 TWD
The Microbio Co ROE history
YEARROEYoY
-8.50 %-20.42%
-10.68 %+6.93%
-9.99 %-892.55%
1.26 %-164.30%
-1.96 %-140.08%
4.89 %-224.03%
-3.94 %-58.15%
-9.42 %-234.03%
7.03 %-289.85%
-3.70 %+46.18%
-2.53 %+40.08%
-1.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Microbio Co's Return on Equity (ROE)

Microbio Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Microbio Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Microbio Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Microbio Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Microbio Co stock

Return on Equity (ROE) of Microbio Co is -8.50 % in 2025.

Return on Equity (ROE) of Microbio Co changed from -10.68 % to -8.50 %, representing a -20.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Microbio Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Microbio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Microbio Co

All Key Metrics — Microbio Co